Simplex Trading, LLC Vir Biotechnology, Inc. Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

A detailed history of Simplex Trading, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 4,273 shares of VIR stock, worth $31,620. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,273
Previous 17,953 76.2%
Holding current value
$31,620
Previous $159,000 79.87%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$7.26 - $10.7 $99,316 - $146,376
-13,680 Reduced 76.2%
4,273 $32,000
Q2 2024

Jul 25, 2024
BUY
$7.63 - $12.66 $100,876 - $167,377
13,221 Added 279.4%
17,953 $159,000
Q1 2024

Apr 25, 2024
BUY
$8.6 - $11.9 $25,266 - $34,962
2,938 Added 163.77%
4,732 $47,000
Q4 2023

Feb 02, 2024
BUY
$7.76 - $10.29 $13,921 - $18,460
1,794 New
1,794 $18,000
Q3 2022

Nov 04, 2022
BUY
$18.26 - $31.1 $74,537 - $126,950
4,082 New
4,082 $78,000
Q2 2022

Aug 03, 2022
SELL
$19.08 - $26.7 $235,905 - $330,118
-12,364 Closed
0 $0
Q1 2022

May 02, 2022
SELL
$21.19 - $40.01 $197,787 - $373,453
-9,334 Reduced 43.02%
12,364 $318,000
Q4 2021

Feb 23, 2022
BUY
$30.97 - $54.03 $536,121 - $935,313
17,311 Added 394.6%
21,698 $908,000
Q3 2021

Oct 28, 2021
SELL
$34.9 - $54.54 $453 - $709
-13 Reduced 0.3%
4,387 $190,000
Q2 2021

Aug 12, 2021
BUY
$38.75 - $51.0 $170,500 - $224,400
4,400 New
4,400 $208,000
Q4 2020

Feb 02, 2021
SELL
$25.51 - $43.38 $29,106 - $49,496
-1,141 Closed
0 $0
Q3 2020

Oct 14, 2020
BUY
$28.28 - $53.6 $30,570 - $57,941
1,081 Added 1801.67%
1,141 $39,000
Q2 2020

Jul 13, 2020
SELL
$27.89 - $47.86 $1,924 - $3,302
-69 Reduced 53.49%
60 $2,000
Q1 2020

Apr 29, 2020
BUY
$12.04 - $60.2 $1,553 - $7,765
129 New
129 $4,000

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $982M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email